Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07840443 |
| Title | Phase II Study of CAmizestrant in Resectable Endometrial Adenocarcinoma (CARA) |
| Acronym | CARA |
| Recruitment | Not yet recruiting |
| Gender | female |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | University Health Network, Toronto |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| BC Cancer - Vancouver | Vancouver | British Columbia | V5Z 4E6 | Canada | Details | |
| Kingston Health Sciences Centre | Kingston | Ontario | K7L 2V7 | Canada | Details | |
| The Ottawa Hospital | Ottawa | Ontario | K1H 8L6 | Canada | Details | |
| Princess Margaret Cancer Centre/University Health Network | Toronto | Ontario | M5G 2M9 | Canada | Details | |
| Hôpital Maisonneuve-Rosemont | Montreal | Quebec | H1T 2M4 | Canada | Details | |
| Jewish General Hospital | Montreal | Quebec | H3T 1E2 | Canada | Details |